Aligos Therapeutics announced the appointment of David Perry as Vice President of Business Development, effective immediately. Most recently, he served as Senior Director of Business Development at Sangamo Therapeutics.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ALGS:
- Aligos Therapeutics appoints Hardean Achneck as CMO
- Aligos Therapeutics management to meet virtually with Piper Sandler
- Aligos Therapeutics announces results from Phase 2a HERALD study
- Closing Bell Movers: Steelcase down 10% on soft top-line results, guidance
- Aligos Therapeutics to announce Phase 2a topline results for ALG-055009 in MASH